Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
Publisher: Spandidos Publications
E-ISSN: 1792-1015|9|4|1345-1350
ISSN: 1792-0981
Source: Experimental and Therapeutic Medicine, Vol.9, Iss.4, 2015-01, pp. : 1345-1350
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract